A new model of cortical stroke in the rhesus macaque

被引:47
作者
West, G. Alexander [3 ]
Golshani, Kiarash J. [1 ,2 ]
Doyle, Kristian P. [1 ]
Lessov, Nikola S. [1 ]
Hobbs, Theodore R. [4 ]
Kohama, Steven G. [5 ]
Pike, Martin M. [6 ]
Kroenke, Christopher D. [5 ,6 ]
Grafe, Marjorie R. [7 ]
Spector, Maxwell D. [1 ]
Tobar, Eric T. [1 ]
Simon, Roger P. [8 ]
Stenzel-Poore, Mary P. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Dept Neurosurg, Portland, OR 97239 USA
[3] Swedish Med Ctr, Neurotrauma Res Lab, Colorado Brain & Spine Inst, Englewood, CO 80110 USA
[4] Oregon Natl Primate Res Ctr, Div Anim Resources, Beaverton, OR USA
[5] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA
[6] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA
[7] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA
[8] Legacy Good Samaritan Hosp, Dow Neurobiol Labs, Portland, OR USA
关键词
cerebral ischemia; MRI; neurologic deficit; nonhuman primate; rhesus macaque; stroke; MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; NEUROPROTECTIVE DRUGS; NONHUMAN-PRIMATES; BABOON MODEL; MONKEY MODEL; BRAIN-DAMAGE; OCCLUSION; INJURY; REPERFUSION;
D O I
10.1038/jcbfm.2009.43
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primate models are essential tools for translational research in stroke but are reportedly inconsistent in their ability to produce cortical infarcts of reproducible size. Here, we report a new stroke model using a transorbital, reversible, two-vessel occlusion approach in male rhesus macaques that produces consistent and reproducible cortical infarcts. The right middle cerebral artery (distal to the orbitofrontal branch) and both anterior cerebral arteries were occluded with vascular clips. Bilateral occlusion of the anterior cerebral artery was critical for reducing collateral flow to the ipsilateral cortex. Reversible ischemia was induced for 45, 60, or 90 mins (n = 2/timepoint) and infarct volume and neurologic outcome were evaluated. The infarcts were located predominantly in the cortex and increased in size with extended duration of ischemia determined by T-2-weighted magnetic resonance imaging. Infarct volume measured by 2,3,5-triphenyl tetrazolium chloride and cresyl violet staining corroborated magnetic resonance imaging results. Neurologic deficit scores worsened gradually with longer occlusion times. A subset of animals (n=5) underwent 60 mins of ischemia resulting in consistent infarct volumes primarily located to the cortex that correlated well with neurologic deficit scores. This approach offers promise for evaluating therapeutic interventions in stroke. Journal of Cerebral Blood Flow & Metabolism (2009) 29, 1175-1186; doi:10.1038/jcbfm.2009.43; published online 22 April 2009
引用
收藏
页码:1175 / 1186
页数:12
相关论文
共 41 条
[1]  
CLARK WM, 1996, STROKE, V7, P128
[2]   EFFECT OF INTRACAROTID AMOBARBITAL INJECTIONS UPON EXPERIMENTALLY INDUCED EPILEPTIFORM ACTIVITY [J].
COCEANI, F ;
LIBMAN, I ;
GLOOR, P .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1966, 20 (06) :542-+
[3]   Middle cerebral artery occlusion in Macaca fascicularis:: acute and chronic stroke evolution [J].
D'Arceuil, HE ;
Duggan, M ;
He, JL ;
Pryor, J ;
de Crespigny, A .
JOURNAL OF MEDICAL PRIMATOLOGY, 2006, 35 (02) :78-86
[4]   Selfotel in acute ischemic stroke - Possible neurotoxic effects of an NMDA antagonist [J].
Davis, SM ;
Lees, KR ;
Albers, GW ;
Diener, HC ;
Markabi, S ;
Karlsson, G ;
Norris, J .
STROKE, 2000, 31 (02) :347-354
[5]   Why do neuroprotective drugs work in animals but not humans? [J].
DeGraba, TJ ;
Pettigrew, LC .
NEUROLOGIC CLINICS, 2000, 18 (02) :475-+
[6]   EXPERIMENTAL ACUTE THROMBOTIC STROKE IN BABOONS [J].
DELZOPPO, GJ ;
COPELAND, BR ;
HARKER, LA ;
WALTZ, TA ;
ZYROFF, J ;
HANSON, SR ;
BATTENBERG, E .
STROKE, 1986, 17 (06) :1254-1265
[7]   Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? [J].
Emerich, DF .
TRENDS IN NEUROSCIENCES, 2000, 23 (06) :245-246
[8]   Recommendations for standards regarding preclinical neuroprotective and restorative drug development [J].
Feinklestein, SP ;
Fisher, M ;
Furland, AJ ;
Goldstein, LB ;
Gorelick, PB ;
Kaste, M ;
Lees, KR ;
Traystman, RJ ;
Albers, GW ;
Anwer, UE ;
Ashwood, T ;
Barone, FC ;
Basta, SL ;
Bogousslavsky, J ;
Buchan, AM ;
Cady, WJ ;
Chan, PH ;
Clemens, JA ;
Cox, BF ;
Craddock, RE ;
Cramer, SC ;
del Zoppo, GJ ;
Dielrich, WD ;
Elliott, P ;
Faden, AI ;
Feuerstein, GZ ;
Ginsberg, MD ;
Gold, M ;
Greene, WL ;
Hall, ED ;
Hsu, CY ;
Hunter, AJ ;
Lai, M ;
Lesko, LM ;
Levy, DE ;
Li, FH ;
Locke, KW ;
Lodge, D ;
Lowe, D ;
Marcoux, FW ;
McCulloch, J ;
McDermott, J ;
Meibach, R ;
Messersmith, EK ;
Moseley, M ;
Moskowitz, MA ;
Mueller, AL ;
Munro, F ;
Nudo, RJ ;
Oeda, J .
STROKE, 1999, 30 (12) :2752-2758
[9]   Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke [J].
Feuerstein, Giora Z. ;
Zaleska, Margaret M. ;
Krams, Michael ;
Wang, Xinkang ;
Day, Mark ;
Rutkowski, Julia L. ;
Finklestein, Seth P. ;
Pangalos, Menelas N. ;
Poole, Michael ;
Stiles, Gary L. ;
Ruffolo, Robert R. ;
LWalsh, Frank .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2008, 28 (01) :217-219
[10]   Enhancing the development and approval of acute stroke therapies - Stroke Therapy Academic Industry Roundtable [J].
Fisher, M .
STROKE, 2005, 36 (08) :1808-1813